EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reduced JAG1 Expression Through miR‐200 Overexpression or Crispr‐Cas Mediated Knockout Impairs TNBC Growth and Metastasis

Megan Vaz, Katrina L Watson, Roger A Moorehead iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Megan Vaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: MicroRNAs, Jagged-1 Protein, Gene Expression Regulation, Neoplastic, Triple Negative Breast Neoplasms. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies from our lab demonstrated that increasing miR‐200 expression in human triple negative breast cancer (TNBC) reduced tumor growth and metastasis In Vivo. In this study, we found that overexpression of miR‐200s in TNBC cells significantly reduced the expression of JAG1 . When JAG1 was knocked out in MDA‐MB‐231 cells proliferation and invasion were significantly reduced In Vitro. Moreover, loss of JAG1 inhibited mammary tumor growth and metastasis In Vivo. RNA sequencing revealed that loss of JAG1 altered the expression of genes associated with the ECM, angiogenesis, and EMT. These results imply that miR‐200s may mediate some of their antitumor actions through reducing JAG1 expression and suggest that agents targeting JAG1 should be further evaluated as a therapeutic strategy for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsJagged-1 ProteinGene Expression Regulation, NeoplasticTriple Negative Breast NeoplasmsHumansAnimalsCell ProliferationFemaleMiceCell Line, TumorCRISPR-Cas SystemsNeoplasm MetastasisCell MovementEpithelial-Mesenchymal TransitionXenograft Model Antitumor Assays

Stichwörter der Autor:innen

JAG1TNBCbreast cancermetastasismiR‐200

Substanzen

MicroRNAsJagged-1 ProteinMIRN200 microRNA, humanJAG1 protein, human

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.

ORCID-Profile: Roger A Moorehead

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Vaz, M., Watson, K. L., & Moorehead, R. A. (2025). Reduced JAG1 Expression Through miR‐200 Overexpression or Crispr‐Cas Mediated Knockout Impairs TNBC Growth and Metastasis. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23937

Vancouver

Vaz M, Watson KL, Moorehead RA. Reduced JAG1 Expression Through miR‐200 Overexpression or Crispr‐Cas Mediated Knockout Impairs TNBC Growth and Metastasis. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23937

BibTeX
@article{Vaz2025,
  author = {Vaz, Megan and Watson, Katrina L and Moorehead, Roger A},
  title = {Reduced JAG1 Expression Through miR‐200 Overexpression or Crispr‐Cas Mediated Knockout Impairs TNBC Growth and Metastasis},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23937}
}
Kostenlos starten →